000 03922cam a2200349 a 4500
003 EG-GiCUC
005 20250223031551.0
008 160929s2016 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.10.05.Ph.D.2016.Ba.P
100 0 _aBardes Bahaa Abdelhakim Hassan
245 1 0 _aPathology and pathogenesis of metastasis in novel nude mouse model of feline mammary cancer /
_cBardes Bahaa Abdelhakim Hassan ; Supervised Sohair Mahmoud Sokkar , Iman Bakr Mohamed , Kawkab Abdelaziz Ahmed
246 1 5 _aباثولوجيا التطور المرضى لانتشار سرطان الثدى القططى فى نماذج الفئران
260 _aCairo :
_bBardes Bahaa Abdelhakim Hassan ,
_c2016
300 _a131 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Clinical Pathology
520 _aFeline mammary carcinoma (FMC) is similar to human breast cancer (HBC) in the late age of onset, incidence, histopathologic features, biologic behavior, and pattern of metastasis. There is a lack of knowledge about the existence and prognostic value of lymphangiogenesis in FMC. Therefore, FMC has been proposed as a relevant model for aggressive HBC. The goals of this study were to 1) develop a nude mouse model of FMC growth and metastasis; 2) measure the expression of genes responsible for lymphangiogenesis, angiogenesis, tumor progression and lymph node metastasis using FMC tissues, mouse xenografts and cell lines; and 3) design an immunohistochemical protocol to differentiate between blood and lymphatic vessels in FMC and to compare blood and lymphatic vessel invasion detected by hematoxylin and eosin (H&E) versus that detected by immunohistochemistry (IHC). Two primary FMC tissues were injected subcutaneously and six FMC cell lines were injected into 3 sites (subcutaneous, intratibial and intracardiac) in nude mice. Tumors and metastases were monitored using bioluminescent imaging and characterized by gross necropsy, radiology and histopathology. Molecular characterization of invasion and metastasis genes in FMC was conducted using qRT-PCR in six primary FMC tissues, two subcutaneous FMC xenografts and six FMC cell lines. A survey study was done on 42 specimens from cats diagnosed with mammary cancer were stained with H&E and classified based on histopathological examination. Eighteen specimens out of 42, characterized by vascular and/or lymphatic invasion, were selected and evaluated by IHC using antibody against prospero-related homeobox domain 1 (PROX1) as lymphatic endothelial marker. The histologic appearance of the subcutaneous xenografts resembled the primary tumors. No metastasis was evident following subcutaneous injection of both tumor tissues and cell lines while lung, brain, liver, kidney and bone metastases were confirmed following intratibial and intracardiac injection of FMC cell lines. Fifteen genes were differentially expressed in the FMC tissue and cell lines and the highly expressed genes in all the samples were PDGFA, PDGFB, PDGFC, FGF2, EGFR, ERBB2, ERBB3, VEGFD, VEGFR3 and MYOF. Finally, PROX1 immunostaining was present in the nucleus of the peritratumoral lymphatic endothelial cells. This investigation demonstrated the usefulness of nude mouse models of experimental FMC and identified molecular targets of FMC progression and metastasis
530 _aIssued also as CD
653 4 _aLung
653 4 _aMammary cancer
653 4 _aMetastasis
700 0 _aIman Bakr Mohamed ,
_eSupervisor
700 0 _aKawkab Abdelaziz Ahmed ,
_eSupervisor
700 0 _aSohair Mahmoud Sokkar ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSoheir
_eCataloger
942 _2ddc
_cTH
999 _c57884
_d57884